Skip to content
FolioFact
FolioFact
Q2 2026 18/58 funds filed
Newest stored record
Sign in Sign up

General Atlantic — Unmapped CUSIP

How General Atlantic's position in Parabilis Medicines changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 698955101 needs mapping

Quarters held
1
First reported
Q2 2026
Latest value
$42,107,678
Latest weight
1.5%
Peak weight
1.5%
Shares since first
0%

Position Trend

Shares, value, and weight from first report to latest report.

General Atlantic first reported 1,538,461 shares in Q2 2026 and most recently reported 1,538,461 shares in Q2 2026. Portfolio weight peaked at 1.5% in Q2 2026; the low reported weight was 1.5% in Q2 2026.

Since the first report, shares are 0% and reported value is 0%. Latest move: NEW

Quarter Shares Value % of portfolio Change
Q2 2026 1,538,461 $42,107,678 1.45% NEW